Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
AMAG Pharmaceuticals (AMAG) PT Raised to $25 at Cowen as Execution Improves
-
AMAG Pharmaceuticals (AMAG) PT Lowered to $20 at Cowen; Makena Autoinjector Approval Another Positive, But Recovery Slow
-
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
-
Notable Analyst Rating Changes 11/7: (PAH) (BIIB) (CMI) Upgraded; (GPRO) (PNR) (BMRN) Downgraded
-
AMAG Pharma (AMAG) Names New CFO
-
AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer
-
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
-
Cowen Starts AMAG Pharmaceuticals (AMAG) at Outperform
-
AMAG Pharmaceuticals Announces Closing of $201 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option
-
AMAG Pharmaceuticals Prices Public Offering of $175 Million of Common Stock
-
AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 34th Annual Healthcare Conference
-
AMAG Pharmaceuticals Announces Pricing of $175 Million of 2.50% Convertible Senior Notes Due 2019
-
Morning Movers 10/29: FMR, VVUS, MWW, CSTR, TNAV, PTEK, AXTI, EL Higher; NUVA, NR, AMAG, VLCM, TNCC, SNBC, EXAS Lower
-
Notable Analyst Rating Changes 07/29: CTXS, BA, ENTR, TTEK Upgraded; NVDA,, VPRT, SYMC, AMAG Downgraded
-
Morning Movers 7/29: NMTI, VCBI, NEWP, MOD, FVE, ATX, CTXS, CML Higher; VPRT, NENG, BBW, ASIA, QTM, CVD Lower
-
Pre-Open Movers 9/2: Sciele Pharma (SCRX) Higher On Buyout; Airlines (DAL, AMR, LCC, etc.) Up On Drop in Crude